Want to join the conversation?
$DGX's 3Q15 reported operating income was $631MM, or 33.6% of revenues which benefited from the pre-tax gain of $334MM on the contribution to the clinical trials joint venture. In Oct., new companion diagnostic solutions were separately announced for two recent FDA approved therapies for non-small cell lung cancer.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?